Katherine Rizzo
Psychiatry · Clearwater, FLNPI 1508392820
Payments from drug & device makers
Across 220 payments — averaging $25.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$687
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$686
- Neuronetics, Inc.$627
- Teva Pharmaceuticals USA, Inc.$447
- Neurocrine Biosciences, Inc.$430
- Otsuka America Pharmaceutical, Inc.$396
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,61699%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $687 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $686 |
| Neuronetics, Inc. | 12 | $627 |
| Teva Pharmaceuticals USA, Inc. | 16 | $447 |
| Neurocrine Biosciences, Inc. | 13 | $430 |
| Otsuka America Pharmaceutical, Inc. | 15 | $396 |
| Alkermes, Inc. | 17 | $362 |
| Vanda Pharmaceuticals Inc. | 11 | $347 |
| Axsome Therapeutics, Inc. | 10 | $338 |
| Johnson & Johnson | 15 | $314 |
| Supernus Pharmaceuticals, Inc. | 8 | $226 |
| Indivior Inc. | 8 | $163 |
| Lundbeck LLC | 6 | $135 |
| Eisai Inc. | 4 | $123 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $76 |
| Corium, LLC | 3 | $73 |
| Neos Therapeutics, LP | 3 | $53 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Alfasigma USA, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Sage Therapeutics, LLC | 1 | $28 |
| Bausch Health US, LLC | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Orexo US, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY$240
- INGREZZA$125
- QELBREE$125
- Auvelity$109
- UZEDY$109
How this compares
$5,663 in reported general payments places this provider in the 80th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 21 | $453 |
| Clonazepam | 27 | $380 |
| Mirtazapine | 11 | $308 |
| Buprenorphine Hcl | 14 | $217 |
| Buspirone Hcl | 17 | $212 |
| Diazepam | 11 | $89 |
| Nortriptyline Hcl | 11 | $88 |
| Risperidone | 14 | $75 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Clearwater
- Michelle ScargleClearwater$926K
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.